Showing 21-30 of 30 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Induction of beta-cell regeneration using EZH2 inhibitors | Baker Heart & Diabetes Institute | Sam El-Osta | Cures | 01-October-2023 to 31-August-2026 | $699.447,00 |
| Harnessing T cell exhaustion for type 1 diabetes prevention | St. Vincent’s Institute of Medical Research | Thomas Kay | Cures | 01-November-2023 to 31-October-2026 | $2.250.000,00 |
| Curing Diabetes using Transgenic Porcine Islet Xenotransplantation | The University of Sydney | Wayne Hawthorne | Cures | 01-February-2024 to 31-January-2027 | $2.249.610,00 |
| ENHANCING TYPE 1 DIABETES RISK PREDICTION AND STRATIFICATION THROUGH INTEGRATED MULTI-OMICS PROFILING OF EARLY BIOMARKERS IN DRIED BLOOD SPOTS | University of New South Wales | Ki Wook Kim | Cures | 01-March-2023 to 29-February-2028 | $999.998,06 |
| MicroRNA signature for early prediction of Type 1 Diabetes progression | Western Sydney University | Wilson Wong | Cures | 01-March-2023 to 28-February-2026 | $229.035,00 |
| Targeted regulatory T cells to treat type 1 diabetes | Monash University | Joshua Ooi | Cures | 01-February-2023 to 31-January-2026 | $510.000,00 |
| Early Prediction of Progression to Autoimmunity in Type 1 Diabetes | Western Sydney University | Anandwardhan Hardikar | Cures | 01-January-2023 to 31-December-2026 | $875.894,43 |
| Examining the Safety and Efficacy of the Android Artificial Pancreas System (AAPS) with advanced bolus free features in adults with Type 1 Diabetes | Baker Heart & Diabetes Institute | Neale Cohen | Improving Lives | 01-October-2022 to 28-February-2026 | $746.100,00 |
| Australian Type 1 Diabetes Clinical Research Network – General Population Screening Pilot and Feasibility | The University of Sydney | Kirstine Bell | Cures | 01-September-2021 to 31-May-2025 | $989.062,66 |
| α-MSH/MC5R axis as an adjunctive therapeutic target for type 1 diabetes | Monash University | Michael Cowley | Improving Lives | 01-August-2019 to 30-September-2025 | $716.962,40 |